|1.||Salas, Eduardo: 1 article (03/2004)|
|2.||Segalés, Estefania: 1 article (03/2004)|
|3.||Vilahur, Gemma: 1 article (03/2004)|
|4.||Badimon, Lina: 1 article (03/2004)|
|5.||Baldellou, María Isabel: 1 article (03/2004)|
03/01/2004 - "LA810 significantly decreased thrombus formation at any degree of vascular damage and shear rate (p<0.001) without hypotensive side-effects or heart rate variations. "
03/01/2004 - "This new anti-ischemic NO-donor (NOd) LA810 that inhibits platelet function without hypotensive side-effects seems a highly efficacious strategy to reduce acute thrombosis triggered by coronary artery disease."
03/01/2004 - "We have studied whether donation of NO with a novel platelet-selective S-nitrosothiol compound (LA810) at a systemic level can inhibit thrombosis elicited by damaged vessel wall (eroded and disrupted vessel wall) at hemodynamic conditions typical of patent and stenotic coronary arteries. "
|2.||Coronary Artery Disease (Coronary Atherosclerosis)
|2.||glucuronyl glucosamine glycan sulfate (Vessel)